Innate Pharma Free Cash Flow Generation Index
Innate Pharma free cash flow generation index. Innate Pharma (IPHA) has a Free Cash Flow Generation Index of 0.91x as of June 2024. Free cash flow of $2.75 Million represents 1% of operating cash flow ($3.04 Million).
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Free Cash Flow Generation Index of Innate Pharma (2006–2019)
Free cash flow generation index of Innate Pharma from 2006 to 2019. Historical FCF Generation Index trend for Innate Pharma across 4 annual periods. See IPHA financial flexibility score to measure the company's free cash flow as a share of total liabilities.
Innate Pharma Free Cash Flow Generation Index by Year (2006–2019)
Innate Pharma free cash flow generation index by year from 2006 to 2019. Year-by-year Free Cash Flow Generation Index for Innate Pharma. For the full cash flow conversion analysis, see Innate Pharma cash conversion from operations.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2019 | -0.87x | $-30.48 Million | $34.92 Million | $65.40 Million | ▼ -190.5% |
| 2015 | 0.96x | $200.51 Million | $207.91 Million | $7.40 Million | ▼ -1.1% |
| 2011 | 0.98x | $12.66 Million | $12.99 Million | $322.00K | ▲ +189.6% |
| 2006 | -1.09x | $-392.00K | $360.00K | $752.00K | — |